These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16088366)

  • 81. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.
    Kiwanuka N; Robb M; Kigozi G; Birx D; Philips J; Wabwire-Mangen F; Wawer MJ; Nalugoda F; Sewankambo NK; Serwadda D; Gray RH
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):721-5. PubMed ID: 15167291
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Thailand beats the odds in completing vaccine test.
    Cohen J
    Science; 2003 Sep; 301(5640):1663. PubMed ID: 14500958
    [No Abstract]   [Full Text] [Related]  

  • 83. The feasibility of HIV vaccine efficacy trials among Russian injection drug users.
    Beyrer C; Baral S; Shaboltas A; Dukhovlinova E; Masharsky A; Verevochkin S; Latkin C; Heimer R; Hoffman I; Kozlov A
    Vaccine; 2007 Oct; 25(41):7014-6. PubMed ID: 17707960
    [TBL] [Abstract][Full Text] [Related]  

  • 84. HIV vaccine trials: will intravenous drug users enroll?
    Meyers K; Metzger DS; Navaline H; Woody GE; McLellan AT
    Am J Public Health; 1994 May; 84(5):761-6. PubMed ID: 8179045
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.
    Etcheverry MF; Evans JL; Sanchez E; Mendez-Arancibia E; Meroño M; Gatell JM; Page K; Joseph J
    Hum Vaccin Immunother; 2013 Feb; 9(2):420-9. PubMed ID: 23291931
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs.
    Yakovenko I; Hyshka E; Tyrrell L; Wild TC
    J Subst Abuse Treat; 2019 Jun; 101():67-71. PubMed ID: 31174715
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Lack of volunteers for vaccine.
    AIDS Patient Care STDS; 1999 Sep; 13(9):572. PubMed ID: 10813047
    [No Abstract]   [Full Text] [Related]  

  • 88. Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.
    Voytek CD; Jones KT; Metzger DS
    Vaccine; 2011 Aug; 29(36):6130-5. PubMed ID: 21704110
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Decisions to participate in research: views of underserved minority drug users with or at risk for HIV.
    Slomka J; Ratliff EA; McCurdy SA; Timpson S; Williams ML
    AIDS Care; 2008 Nov; 20(10):1224-32. PubMed ID: 18608070
    [TBL] [Abstract][Full Text] [Related]  

  • 90. HIV-1 antibody testing among drug users participating in AIDS education.
    McCusker J; Bigelow C; Zapka JG; Zorn M; Stoddard AM; Lewis BF
    Patient Educ Couns; 1994 Dec; 24(3):267-78. PubMed ID: 7753720
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military.
    McGrath JW; George K; Svilar G; Ihler E; Mafigiri D; Kabugo M; Mugisha E
    J Acquir Immune Defic Syndr; 2001 Aug; 27(4):381-8. PubMed ID: 11468427
    [TBL] [Abstract][Full Text] [Related]  

  • 92. HIV vaccine preparedness studies in the non-organization for economic co-operation and development (non-OECD) countries.
    Dhalla S; Nelson KE; Singer J; Poole G
    AIDS Care; 2009 Mar; 21(3):335-48. PubMed ID: 18781449
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Determinants of participation in HIV clinical trials: the importance of patients' trust in their provider.
    Volkmann ER; Claiborne D; Currier JS
    HIV Clin Trials; 2009; 10(2):104-9. PubMed ID: 19487180
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Trial-related discrimination in HIV vaccine clinical trials.
    Allen M; Israel H; Rybczyk K; Pugliese MA; Loughran K; Wagner L; Erb S
    AIDS Res Hum Retroviruses; 2001 May; 17(8):667-74. PubMed ID: 11429107
    [TBL] [Abstract][Full Text] [Related]  

  • 95. HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.
    Etcheverry MF; Lum PJ; Evans JL; Sanchez E; de Lazzari E; Mendez-Arancibia E; Sierra E; Gatell JM; Page K; Joseph J
    Vaccine; 2011 Feb; 29(10):1991-6. PubMed ID: 21241735
    [TBL] [Abstract][Full Text] [Related]  

  • 96. "Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.
    Newman PA; Yim S; Daley A; Walisser R; Halpenny R; Cunningham W; Loutfy M
    Vaccine; 2011 Jan; 29(3):451-8. PubMed ID: 21075163
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Willingness to Participate and Associated Factors in a Zika Vaccine Trial in Indonesia: A Cross-Sectional Study.
    Harapan H; Mudatsir M; Yufika A; Nawawi Y; Wahyuniati N; Anwar S; Yusri F; Haryanti N; Wijayanti NP; Rizal R; Fitriani D; Maulida NF; Syahriza M; Ikram I; Fandoko TP; Syahadah M; Asrizal FW; Jamil KF; Rajamoorthy Y; Wagner AL; Groneberg DA; Kuch U; Müller R; Sasmono RT; Imrie A
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30453663
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Barriers to participation in actual HIV vaccine trials.
    Dhalla S; Poole G
    Curr HIV Res; 2013 Apr; 11(3):238-45. PubMed ID: 23721228
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [The acceptability of experimentation on the efficacy of an anti-HIV vaccine among Italian drug addicts].
    Nicolosi A
    Ann Ig; 1999; 11(1):27-34. PubMed ID: 10208041
    [No Abstract]   [Full Text] [Related]  

  • 100. Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada.
    Fleming T; Valleriani J; Ng C; Maher L; Small W; McNeil R
    BMC Public Health; 2020 Jul; 20(1):1081. PubMed ID: 32646390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.